Abstract:Objective With a quasi-experimental design, this study aims to assess whether the Zero-markup Policy for Essential Drugs (ZPED) reduces the medical expense for patients at county hospitals, the major healthcare provider in rural China. Methods Data from Ningshan county hospital and Zhenping county hospital, China, include 2014 outpatient records and 9239 inpatient records. Quantitative methods are employed to evaluate ZPED. Both hospital-data difference-in-differences and individual-data regressions are applied to analyze the data from inpatient and outpatient departments. Results In absolute terms, the total expense per visit reduced by 19.02 CNY (3.12 USD) for outpatient services and 399.6 CNY (65.60 USD) for inpatient services. In relative terms, the expense per visit was reduced by 11% for both outpatient and inpatient services. Due to the reduction of inpatient expense, the estimated reduction of outpatient visits is 2% among the general population and 3.39% among users of outpatient services. The drug expense per visit dropped by 27.20 CNY (4.47 USD) for outpatient services and 278.7 CNY (45.75 USD) for inpatient services. The proportion of drug expense out of total expense per visit dropped by 11.73 percentage points in outpatient visits and by 3.92 percentage points in inpatient visits. Conclusion Implementation of ZPED is a benefit for patients in both absolute and relative terms. The absolute monetary reduction of the per-visit inpatient expense is 20 times of that in outpatient care. According to cross-price elasticity, the substitution between inpatient and outpatient due to the change in inpatient price is small. Furthermore, given that the relative reductions are the same for outpatient and inpatient visits, according to relative thinking theory, the incentive to utilize outpatient or inpatient care attributed to ZPED is equivalent, regardless of the 20-times price difference in absolute terms.

The definition of dispensing fee and the methods of estimation in China

A feasibility study on the implementation of dispensing fee in China

A review on international experience of implementing dispensing fee

The debate on charging dispensing fee in health settings in China

Study on Charging Level of Pharmaceutical Service Fee in China

Study on Pricing Methods of Pharmaceutical Service Fee in hospitals

Study on the Compensation Mechanisms of Pharmaceutical Service and Charging Methods of Dispensing Fee in Several Foreign Countries or Regions

A Description of Outpatient Drug Use in Rural China: Evidence of Differences Due to Insurance Coverage.

A STUDY OF FEES FOR INPATIENT CARE IN THE THREE STUDY COUNTY HOSPITALS OF POOR RURAL CHINA

Introduction of Dispensing Payment in Japanese Social Pharmacy

Development History of Japanese Hospital Dispensing Fee

Research on Determinations of the Hospitalization Expenses: Empirical Analysis Based on a Survey of Hospitals

Medicine Use and Cost Analysis by Prescriptions of Community Health Service Institutions in Chengdu and Shenyang

Experiences on Reimbursement of Classified Drugs in Other Countries and Areas

Analysis of the "regulation of Drug Price Difference (trial Implementation)" in China

Deviation between cost and government mandated price in bed utilization in public hospitals and corresponding strategy

The Financial Impact of the ‘Zero-Markup Policy for Essential Drugs’ on Patients in County Hospitals in Western Rural China

Comparative analysis on the price of essential medicines:Based on the sample survey of primary health care institutions and pharmacies in 18 provinces

Invesitigation on Pilot Medical Fees in Public Hospitals in Beijing City

Study of Payment on Inpatients of Zhejiang province

Analysis of the Feasibility of Setting Differential Margin Mode for Drug Selling in Public Hospitals in China